Torrent Pharmaceuticals Share Price
Large Cap | Pharmaceuticals and health care | NSE: TORNTPHARM | BSE: 500420
₹3,286.50 38.80 (1.19 %)
Last Updated: 04 Apr 2025 03:59 PM
Overview
Open (₹) 3,248.50
High (₹) 3,309.65
Low (₹) 3,180.00
Prev. Close (₹) 3,247.70
Volume 5,13,622
VWAP (₹) 2,947.64
ROCE (%) 27.16
Industry P/E 44.73
TTM P/E 59.73
P/B Ratio 16.22
Market Cap (₹) Cr.1,11,230.09
Dividend Yield (%)0.85
EPS (₹) 48.94
ROE24.16%
Sales Growth (%) 11.51
Profit Growth (%)33.02
Day Range
3,309.653,309.65
52 Week Range
2,508.653,589.95
Historical Returns
Returns (6M)
-3.48 %
Returns (1Y)
27.53 %
Returns (3Y)
140.48 %
Returns (5Y)
179.18 %
Returns (6M)
-3.48 %
Returns (1Y)
27.53 %
Returns (3Y)
140.48 %
Returns (5Y)
179.18 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (33.03%) TTM EPS Growth
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 33.03% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
RSI 46.45
MFI 26.60
ATR 98.48
Commodity Channel Index -154.58
ROC125 -14.16
ROC21 -12.21
Williams %R -91.30
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 2,979.30 | 3,010.50 | 3,044.40 | 2,945.40 | 2,914.20 | 2,880.30 | 2,849.10 |
Week Ago | 3,089.31 | 3,139.28 | 3,171.41 | 3,057.18 | 3,007.21 | 2,975.08 | 2,925.11 |
Month Ago | 3,353.14 | 3,391.47 | 3,438.94 | 3,305.67 | 3,267.34 | 3,219.87 | 3,181.54 |
EMA & SMA
3286.50
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 3016.96
9 Day 3048.06
10 Day 3033.53
12 Day 3056.07
14 Day 3076.02
20 Day 3102.41
26 Day 3150.71
50 Day 3236.75
100 Day 3268.83
200 Day 3174.18
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
UBS PRINCIPAL CAPITAL ASIA LIMITED | block | Sell | 23 Jan, 2025 | ₹3,252.10 | 44,810 | NSE |
UBS AG | block | Buy | 23 Jan, 2025 | ₹3,252.10 | 44,810 | NSE |
SEB FUND 3 SEB PENSION FUND | block | Sell | 07 Mar, 2024 | ₹2,691.20 | 63,294 | NSE |
SEB ASIENFOND EX JAPAN | block | Buy | 07 Mar, 2024 | ₹2,691.20 | 63,294 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 14 Nov, 2022 | ₹1,669.05 | 1,59,853 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 14 Nov, 2022 | ₹1,669.05 | 1,59,853 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Nov, 2022 | ₹1,694.30 | 1,59,853 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Nov, 2022 | ₹1,694.30 | 1,59,853 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Oct, 2022 | ₹1,559.85 | 1,32,232 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Oct, 2022 | ₹1,559.85 | 1,32,232 | NSE |
INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD. | bulk | Sell | 29 May, 2020 | ₹2,365.32 | 11,49,669 | NSE |
BLACKROCK ADVISORS LLC A/C THE MASTER TRUST BANK OF JAPAN L | bulk | Buy | 29 May, 2020 | ₹2,367.20 | 20,40,623 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
29 Nov, 2024 | Jinesh Shah Designated Person in capacity of trustee of Jinesh Trust | Acquisition | ₹ | 9,30,144 | NSE |
20 Oct, 2021 | Shailesh Haribhakti | Pledge | ₹2,793.90 | 3,600 | NSE |
25 Jun, 2021 | Shailesh Haribhakti | Acquisition | ₹2,899.91 | 6,875 | NSE |
03 Jun, 2021 | Shailesh Haribhakti | Acquisition | ₹2,803.83 | 1,050 | NSE |
02 Jun, 2021 | Shailesh Haribhakti | Acquisition | ₹2,750.01 | 1,820 | NSE |
01 Jun, 2021 | Shailesh Haribhakti | Acquisition | ₹2,736.97 | 730 | NSE |
06 Jan, 2021 | Harish Guttikar | Disposal | ₹2,778.00 | 200 | NSE |
06 Jan, 2021 | Harish Guttikar | Acquisition | ₹2,716.00 | 400 | NSE |
03 Oct, 2020 | Karan Shah | Acquisition | ₹2,146.88 | 1,085 | NSE |
03 Oct, 2020 | Karan Shah | Disposal | ₹2,202.56 | 117 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
14 Jan, 2025 | Rs.26.0000 per share(520%)Interim Dividend | 31 Jan, 2025 | 01 Feb, 2025 |
24 May, 2024 | Rs.6.0000 per share(120%)Final Dividend | 21 Jun, 2024 | 21 Jun, 2024 |
12 Jan, 2024 | Rs.22.0000 per share(440%)Interim Dividend | 12 Feb, 2024 | 12 Feb, 2024 |
25 May, 2022 | Bonus issue of equity shares in the ratio of 1:1 of Rs. 5/-. | 08 Jul, 2022 | 11 Jul, 2022 |
Announcements
Date | Source | Detail |
---|---|---|
28 Mar, 2025 | NSE India | Torrent Pharmaceuticals Limited has informed the Exchange about Closure of Trading Window |
28 Mar, 2025 | NSE India | Torrent Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
26 Mar, 2025 | NSE India | Torrent Pharmaceuticals Limited has informed the Exchange about issue of Securities |
26 Mar, 2025 | BSE India | Intimation regarding Issue of Commercial Papers |
26 Mar, 2025 | BSE India | Redemption of Commercial paper issued under ISIN iINE685A14112 |
26 Mar, 2025 | NSE India | Torrent Pharmaceuticals Limited has informed the Exchange regarding ''Redemption of Commercial Papers issued under ISIN INE685A14112''. |
25 Mar, 2025 | NSE India | Torrent Pharmaceuticals Limited has informed the Exchange about issue of Securities |
25 Mar, 2025 | BSE India | Intimation regarding issuance of Commercial Papers |
19 Mar, 2025 | NSE India | Torrent Pharmaceuticals Limited has informed the Exchange about Credit Rating |
27 Feb, 2025 | NSE India | Torrent Pharmaceuticals Limited has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results & Others | To consider, 1.Interim Dividend . 2. Other business matters. | 15 Jan, 2025 | 24 Jan, 2025 |
Quarterly Results | -- | 11 Oct, 2024 | 25 Oct, 2024 |
Quarterly Results | -- | 08 Jul, 2024 | 23 Jul, 2024 |
Audited Results & Final Dividend | -- | 13 May, 2024 | 24 May, 2024 |
Quarterly Results & Interim Dividend | -- | 15 Jan, 2024 | 02 Feb, 2024 |
Quarterly Results | -- | 10 Oct, 2023 | 23 Oct, 2023 |
Quarterly Results | -- | 18 Jul, 2023 | 07 Aug, 2023 |
Audited Results & Final Dividend | -- | 17 May, 2023 | 30 May, 2023 |
Quarterly Results & Interim Dividend | -- | 13 Jan, 2023 | 25 Jan, 2023 |
Quarterly Results | -- | 06 Oct, 2022 | 21 Oct, 2022 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 68.31% | 71.25% | 71.25% | 71.25% | 71.25% |
Foreign Institutions + | 16.17% | 14.08% | 12.09% | 11.63% | 11.96% |
Domestic Institutions + | 8.35% | 7.21% | 8.87% | 8.93% | 8.08% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 7.17% | 7.46% | 7.79% | 8.19% | 8.71% |
Others | 0% | 0% | 0% | 0% | 0% |
About Torrent Pharmaceuticals
Torrent Pharmaceuticals is a Public Limited Listed company incorporated on 15/07/1972 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1972PLC002126 and registration number is 002126. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 8532.90 Cr. and Equity Capital is Rs. 169.23 Cr. for the Year ended 31/03/2024.
Parent Organisation
Torrent Group
Founded
1972
Managing Director
-- --
NSE Symbol
TORNTPHARM
Torrent Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Sudhir Mehta | Chairman Emeritus |
Mr. Samir Mehta | Executive Chairman |
Mr. Aman Samir Mehta | Whole Time Director |
Mr. Jinesh Shah | Director - Operations |
Mr. Jinal Mehta | Non Executive Director |
Mr. Manish Mahendra Choksi | Independent Director |
Dr. Maurice Chagnaud | Independent Director |
Mr. Nikhil Khattau | Independent Director |
Ms. Ameera Shah | Independent Director |
Ms. Nayantara Bali | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Torrent Pharmaceuticals
What is the share price of Torrent Pharmaceuticals?
The share price of Torrent Pharmaceuticals on 04 Apr, 2025 is ₹ 3,286.50.
What is 52W high and 52W low share price of Torrent Pharmaceuticals?
The highest and lowest 52W share prices of Torrent Pharmaceuticals are ₹ 3589.950 and ₹ 2508.650
What is the market cap of Torrent Pharmaceuticals?
The market capitalization of Torrent Pharmaceuticals as of 04 Apr, 2025 is ₹ 1,11,230.09 Crores
What is the P/E ratio of Torrent Pharmaceuticals?
The current P/E ratio of Torrent Pharmaceuticals as of 04 Apr, 2025 is 44.73
What is the PB ratio of Torrent Pharmaceuticals?
The PB ratio of Torrent Pharmaceuticals as of 04 Apr, 2025 is 16.22
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)